Skip to main content
. 2022 Aug 16;23(9):3948–3959. doi: 10.1021/acs.biomac.2c00791

Figure 9.

Figure 9

Post-thaw drug screening tests on cryopreserved cell monolayers. (A) Schematic of the drug screening process used on cryopreserved monolayers. (B) Cell viability of A549 (black) and HepG2 (blue) monolayers was monitored by resazurin reduction following treatment with doxorubicin (0–250 μg mL–1, 24 h). Percentage cell viability was calculated relative to an untreated control sample ± SEM from 2 independent repeats.